Navigation Links
Gold Standard/Elsevier first to launch state, federal controlled substance drug schedules
Date:8/27/2010

TAMPA, FL August 27, 2010 Gold Standard/Elsevier, developer of drug databases and medication management solutions, announced today the availability of its new Alchemy State and Federal module, the first and only database to offer both state and federal controlled substance drug schedules.

The Alchemy State and Federal module will help providers comply with 41 state-mandated Prescription Drug Monitoring Programs (PDMPs) and federal regulations, while also controlling increasingly widespread prescription drug abuse. Substance Abuse Treatment Admissions Involving Abuse of Pain Relievers: 1998-2008 , a July 2010 White House study, reported a 400 percent increase in substance abuse treatment admissions for prescription pain relievers between 1998 and 2008.

"Alchemy State and Federal delivers rapid, reliable answers for informed prescribing and dispensing and protects against illegal transmission of electronic prescriptions by identifying differences between federal and state Drug Enforcement Administration information," said Marianne Messer, President of Gold Standard. "Through this new module, the only one of its kind on the market today, we take another big step in supporting the many providers whose quest it is to reduce prescription medication misuse and alleviate clinical and financial risks to millions of patients."

Many pharmacy companies face difficulties in complying with their state PDMPs due to variances caused by conflicting state and federal rules. Some state PDMPs have even added drugs excluded from federal regulations. Alchemy State and Federal controlled substance drug schedule offers a solution by allowing pharmacists to identify and track the growing list of drugs unique to each state's list of reportable substances.

Alchemy State and Federal supplies a drug's state-specific legend status and DEA classification for those instances when state regulations are more restrictive than federal regulations. Drugs are identified by state, classification ID, National Drug Code (NDC), and start/end date. To ensure timeliness of database information, Gold Standard monitors materials such as the National Association of Boards of Pharmacy's Survey of Pharmacy Law and state board of pharmacy newsletters.

In addition to controlled substance drug schedules, the Alchemy State and Federal module provides data to support compliance with FDA guidelines for consumer medication information (CMI), including: MedGuide flags and associated MedGuides, Patient Package Insert (PPI) flags with mandatory or permissive indicators, Black Box flags with codified reasons, and REMs flags with codified descriptions that are unique to Alchemy.

"Using advanced technologies, Alchemy State and Federal incorporates emerging industry standards and delivers alerts on pending regulatory changes more rapidly and effectively than any other drug database on the market. We are continuously upgrading Alchemy by keeping our product development and customer service highly responsive to the needs of our clients, ensuring the most agile and innovative drug database and decision support resource," Messer said.


'/>"/>

Contact: Tom Reller
T.Reller@Elsevier.com
212-462-1912
Elsevier
Source:Eurekalert

Related medicine news :

1. Gold Standard/Elsevier promotes medication safety and compliance via New MEDcounselor languages
2. Southampton to conduct UKs first cochlear implant operation to give sound in both ears
3. Neuralstem files FDA application for first chronic spinal cord injury stem cell trial
4. K-State professors book is first to explore Two-Spirit literature in Northwest native groups
5. Deaf, hard-of-hearing students perform first test of sign language by cell phone
6. CRF announces late breaking trials and first report investigations to be presented at TCT 2010
7. Doctors hard to find for patients in Massachusetts first for-profit health plan
8. Scientists develop the first model for investigating the origins of testicular cancer in humans
9. UCLA scientists for the first time identify a cell-of-origin for human prostate cancer
10. Why the MRC didnt fund research that led to the birth of the worlds first test tube baby
11. UCLA scientists isolate the first stages of tissue production in human embryonic stem cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Saint Francis Hospital ... years, and the efforts have paid off. Since implementation of these efforts, ... care to enhance perioperative patient experiences and reduce costly complications. Since implementation in ...
(Date:5/26/2016)... ... May 26, 2016 , ... Development Team of Pixel ... for FCPX. , "This new layered style transition tool will keep a consistent flow ... CEO of Pixel Film Studios. , TranSweep is an all new layered style ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... industry leader in Blood Pressure products . , High blood pressure affects ... effects. Left untreated, high blood pressure can lead to heart disease, stroke, kidney ...
(Date:5/25/2016)... ... May 26, 2016 , ... The United States Food and Drug Administration ... both men and women. To date, the company is the first and only manufacturer ... adult who suffers with androgenetic alopecia. , “This new level of clearance substantiates ...
(Date:5/25/2016)... ... 25, 2016 , ... The Georgia State University College of Law new building ... Design Commission. , The annual award recognizes projects, programs, individuals and organizations that have ... of its physical heritage and the balance between the old and the new. , ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... LONDON , May 24, 2016 ... erfüllt beide primären Endpunkte ... und Überlegenheit in ‚ausgezeichneter plus guter ... aufsteigenden Colons    ,      (Logo: ... B.V. gab heute neue positive Daten von der ...
(Date:5/24/2016)... -- NxStage Medical, Inc. (Nasdaq: NXTM ), a ... today announced that Jeffrey H. Burbank , Chief ... of investor conferences. Where applicable, a webcast of the ...   ... Friday, June 10, 2016 1:30 p.m. ET ...
(Date:5/24/2016)... HONG KONG , May 24, 2016 /PRNewswire/ ... primer stent de doble terapia del mundo, introduce ... fístula arteriovenosa. OrbusNeich, una compañía global ... cambian las vidas, ha expandido su cartera incluyendo ... catéteres balón JADE™ y Scoreflex™ PTA son los ...
Breaking Medicine Technology: